🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Todd Sherer

Michael J. Fox Foundation

ORCID: 0000-0001-9667-6600
MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.6Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts

npj Parkinson s Disease(2024)10.1038/s41531-024-00789-w
Top 25%
0.813DataRank
Top 25%37 citations

Gennaro Pagano, Michael C. Brumm, Caroline Gochanour, Kathleen L. Poston, Daniel Weintraub +95 more

Papers

Driven by 8 papers — median percentile 75. Top paper: “Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts”.

Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts

npj Parkinson s Disease(2024)10.1038/s41531-024-00789-w
Top 25%
0.813DataRank
Top 25%37 citations

Gennaro Pagano, Michael C. Brumm, Caroline Gochanour, Kathleen L. Poston, Daniel Weintraub +95 more

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

npj Parkinson s Disease(2022)10.1038/s41531-022-00404-w
Top 26%
0.783DataRank
Top 26%19 citations

Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey +85 more

Disease modification and biomarker development in Parkinson disease

Neurology(2020)10.1212/wnl.0000000000009107
N/A
0.738DataRank · unranked
136 citations

Lorraine V. Kalia, Ziv Gan‐Or, Caroline H. Williams‐Gray, Philippe L. Bédard, Steven M. Rowe +21 more

Long-Term Dementia Risk in Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000209699
N/A
0.654DataRank · unranked
77 citations

Caroline Gochanour, Chelsea Caspell‐Garcia, Roseanne D. Dobkin, Dag Aarsland, Roy N. Alcalay +88 more

Urinary bis(monacylglycerol) phosphate (BMP) levels are higher in LRRK2 and GBA1 variant carriers but do not predict disease progression in PPMI cohorts

Research Square(2022)10.21203/rs.3.rs-2065993/v1
N/A
0.104DataRank · unranked
1 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +15 more

Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia

medRxiv(2024)10.1101/2024.12.12.24318917
N/A
0DataRank · unranked
0 citations

Anuprita R Nair, Ryan Kurth, Michael C. Brumm, Michele K. York, Roseanne D. Dobkin +20 more

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers: The PPMI cohort

Research Square(2022)10.21203/rs.3.rs-1719882/v1
N/A
0DataRank · unranked
3 citations

Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey +11 more

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts

npj Parkinson s Disease(2023)10.1038/s41531-023-00468-2
N/A
0DataRank · unranked
42 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +16 more